Potential 'universal' blood test for cancer discovered
Researchers from the University of Bradford, UK, have devised a simple blood test that can be used to diagnose whether people have cancer or not.
Jul 28, 2014
0
0
Researchers from the University of Bradford, UK, have devised a simple blood test that can be used to diagnose whether people have cancer or not.
Jul 28, 2014
0
0
A team at the Medical University of South Carolina and Cincinnati Children's has developed a sophisticated model for studying the diseased colon that could lead to the development of personalized treatments for colon-related ...
Nov 20, 2023
0
32
Milk consumption has been linked to improved health, with decreased risks of diabetes, metabolic syndrome, and colon cancer. A group of scientists in Sweden found that lactoferricin4-14 (Lfcin4-14), a milk protein with known ...
Oct 3, 2012
0
0
Cancer researchers at the University of Bergen (UiB) in Norway have in the recent years experienced with hundreds of known drugs, to see how they influence cancer cells.
Nov 15, 2017
0
11
Inflammatory bowel disease (IBD), of which Crohn's disease and ulcerative colitis are the main types, is on the increase in the United States, affecting more than 1.6 million people and explaining perhaps the increase in ...
May 17, 2016
0
47
A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered chemotherapy. ...
Dec 2, 2013
0
0
Metastasis occurs when tumor cells "migrate" to other organs through the bloodstream. Scientists have now discovered the trick tumor cells use to invade tissue from the blood vessels: They produce signaling proteins to make ...
Jul 10, 2012
0
0
It means cancer "in place" but a carcinoma "in situ" often does not want to keep its place. Standing between a cancer cell in situ and the surrounding tissue of fibroblasts and extracellular matrix is the basement membrane, ...
Dec 5, 2014
0
0
About 40-50% of all colorectal patients relapse in the form of metastasis. In the last three years, several molecular classifications have been proposed to identify colorectal cancer patients at risk of relapse. Today in ...
Feb 23, 2015
0
24
Researchers at Boston University School of Medicine (BUSM) have identified a new potential target protein (c-Cbl) they believe can help further the understanding of colon cancer and ultimately survival of patients with the ...
Jul 18, 2018
0
0